Dr. Matthew J Brown is a pharmacist who is specialized in Psychiatric in Cincinnati, Ohio. Patients can reach him at 3200 Vine St, Cincinnati or contact him on 513-861-3100. Active license number of Dr. Matthew J Brown is 03328714 for Psychiatric in Ohio. Dr. Matthew J Brown is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Dr. Matthew J Brown speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Matthew J Brown
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Male
Location:
3200 Vine St, Cincinnati, Ohio, 45220-2213
Phone:
513-861-3100
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Matthew J Brown are as mentioned below.
NPI Number:
1740531391
NPI Enumeration Date:
23 Sep, 2012
NPI Last Update On:
23 Sep, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Matthew J Brown are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
03328714
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2331 Kenilworth Ave, Cincinnati, Ohio
Zip:
45212-3307
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Matthew J Brown at 3200 Vine St, Cincinnati, Ohio or can call on phone at 513-861-3100.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.